Stay updated with breaking news from Patricka Treanor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sebetralstat Phase 3 KONFIDENT and KVD824 Phase 2 KOMPLETE Clinical Trial Enrollment on Track - Formal Notification Received of Sebetralstat EU Orphan Drug Status - KalVista Pharmaceuticals, Inc.
– Sebetralstat Phase 3 KONFIDENT and KVD824 Phase 2 KOMPLETE Clinical Trial Enrollment on Track –– Formal Notification Received of Sebetralstat EU Orphan Drug Status –CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused...
- Patrick A. Treanor Appointed Effective Immediately - - Dan Soland Resigns in Planned Transition - KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused